Vitamin D as a supplementary agent in the treatment of pulmonary tuberculosis: A systematic review and meta-analysis of randomized controlled trials

H. Riaz, I. Riaz, T. Abir, M. Badshah, A. Milton (Karachi, Pakistan; Tucson, New York, Newcastle, United States Of America; Sydney, Australia)

Source: Annual Congress 2013 –Tuberculosis susceptibility: genetic polymorphism and vitamin D deficiency
Session: Tuberculosis susceptibility: genetic polymorphism and vitamin D deficiency
Session type: Oral Presentation
Number: 4623
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Riaz, I. Riaz, T. Abir, M. Badshah, A. Milton (Karachi, Pakistan; Tucson, New York, Newcastle, United States Of America; Sydney, Australia). Vitamin D as a supplementary agent in the treatment of pulmonary tuberculosis: A systematic review and meta-analysis of randomized controlled trials. Eur Respir J 2013; 42: Suppl. 57, 4623

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Vitamin D supplementation in childhood asthma: a systematic review and meta-analysis of randomised controlled trials
Source: ERJ Open Res, 8 (1) 00662-2021; 10.1183/23120541.00662-2021
Year: 2022



Late Breaking Abstract: High-dose vitamin D3 during intensive phase treatment of pulmonary tuberculosis: A double-blind randomised controlled trial
Source: Annual Congress 2010 - Clinical tuberculosis
Year: 2010

Supplementation of N-acetylcysteine as an adjuvant in treatment of newly diagnosed pulmonary tuberculosis patients: A prospective, randomized double blind, placebo controlled study
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013

The effect of text messaging on latent tuberculosis treatment adherence: a randomised controlled trial
Source: Eur Respir J, 51 (2) 1701488; 10.1183/13993003.01488-2017
Year: 2018



The clear evidence for pulmonary rehabilitation in chronic lung disease - a review of the most important randomised controlled trials
Source: International Congress 2018 – PG14 The evolving world of pulmonary rehabilitation
Year: 2018


Vitamin E supplementation in the treatment of asthma: a randomised controlled trial
Source: Eur Respir J 2003; 22: Suppl. 45, 104s
Year: 2003

Systematic review of COPD re-exacerbation and exacerbation treatment failure definitions used in randomised controlled trials (RCTs)
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018


Effect of smoking on tuberculosis treatment outcomes: A systematic review and meta-analysis
Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Year: 2021

Clofazimine for the treatment of multidrug-resistant tuberculosis: Prospective, multicenter, randomized controlled study in China
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015

Augmentation therapy for α1-antitrypsin deficiency: a meta-analysis of randomized and non-randomized clinical studies
Source: Eur Respir J 2005; 26: Suppl. 49, 288s
Year: 2005

Adjunctive vitamin D in tuberculosis treatment: meta-analysis of individual participant data
Source: Eur Respir J, 53 (3) 1802003; 10.1183/13993003.02003-2018
Year: 2019



Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials
Source: ERJ Open Res, 5 (2) 00072-2019; 10.1183/23120541.00072-2019
Year: 2019



Vitamin D for the management of asthma: Cochrane systematic review and meta-analysis
Source: International Congress 2016 – Asthma management
Year: 2016


RCT Abstract - Using a smartphone application in COPD patients to increase physical activity following pulmonary rehabilitation. Results of the AMOPUR Study, a multicenter, randomized, controlled study
Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases
Year: 2021



Roflumilast for stable COPD: Meta-analysis of randomized controlled trials
Source: International Congress 2014 – Clinical presentations
Year: 2014


Helium-hyperoxia a novel treatment for optimizing pulmonary rehabilitation: a randomized controlled trial
Source: Eur Respir J 2007; 30: Suppl. 51, 327s
Year: 2007

Clinical effectiveness of triple therapy in the management of COPD: A systematic review
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010


Effectiveness of mandatory treatment for tuberculosis - An observational registry study
Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis
Year: 2013

Patients’ adherence to chronic treatment in lung diseases: Preliminary data from a randomized controlled trial
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016

Video-observed therapy and medication adherence for tuberculosis patients: randomised controlled trial in Moldova
Source: Eur Respir J, 56 (2) 2000493; 10.1183/13993003.00493-2020
Year: 2020